企業プロフィール
Butterfly Network 株価・ニュース・カタリスト
- ティッカー:
- BFLY
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
8.95 USD (+4.92%)
終値
最終更新: 2026年10月2日
1.2B USD
時価総額
株価変動の要因
2026年10月2日 時点で BFLY は 4.92% 上昇し、$8.95 で取引を終えました。現在のニュース監視期間内に同社の新しいニュースは確認されませんでした。
企業概要
Point-of-Care Ultrasound Platform
Butterfly Network develops portable ultrasound systems intended to make medical imaging available wherever clinical decisions are made. Its platform combines handheld hardware, enterprise software, and artificial intelligence for use across hospitals, clinics, emergency settings, medical education, and other care environments.
Ultrasound-on-Chip Hardware
The Butterfly iQ family uses a semiconductor-based transducer architecture that replaces the multiple probes commonly required by conventional ultrasound systems. The current iQ3 device is designed as a single-probe, whole-body system that connects to a mobile device and supports a broad range of scanning applications.
Compass Software and AI
Butterfly Compass provides image acquisition, workflow management, documentation, credentialing, and enterprise connectivity. Compass AI adds guidance and measurement tools intended to help clinicians acquire diagnostic-quality images and standardize ultrasound use across different levels of experience.
Health-System and Education Customers
The company sells devices and software subscriptions to health systems, individual clinicians, medical schools, and international distributors. Enterprise deployments can place ultrasound across multiple departments while giving administrators centralized control over users, data, and clinical workflows.
Butterfly Embedded
Butterfly Embedded licenses the company's ultrasound technology to third parties developing their own medical devices and applications. This model extends the Ultrasound-on-Chip architecture beyond Butterfly-branded products through development collaborations, licensing, and potential component or software revenue.
今後のカタリスト
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。